SEC Whistleblower Settlements Have Resulted in $1 Billion in Awards Paid For Uncovering Violations of Securities Laws
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Whistleblower Lawsuits May Have Helped Reduce Fraudulent Heart Stent Surgeries: Study September 23, 2020 Irvin Jackson Add Your Comments According to the findings of a new study, whistleblower lawsuits and resulting investigations likely pushed hospitals and doctors away from unnecessary heart stent operations, by highlighting widespread problems with patients being pressured to undergo the procedures. Percutaneous coronary interventions (PCI), also known as heart stents, are designed to prop open arteries that are significantly blocked. The procedures can cost $10,000 or more, and are a lucrative practice area for hospitals and top surgeons. Typically, the heart stent procedure is only considered necessary if there is at least a 70% artery blockage. However, in recent years, a number of investigations have highlighted instances where doctors recommended patients undergo unnecessary heart stent procedures to increase their profits and, in some cases, to receive kickbacks from stent manufacturers. Learn More About Whistleblower Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Whistleblower Lawsuits Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers from Emory University and Yale School of Medicine published a research letter this week in the medical journal JAMA Internal Medicine, which found that whistleblowers working with the Department of Justice were able to not only bring down certain doctors who were performing unnecessary, and unethical, heart stent procedures, but also may have had some chilling effect on the practice as a whole. Whistleblowers are able to file lawsuits against government contractors through the U.S. False Claims Act, if they have private knowledge that their employer or another entity has defrauded the government. In the medical cases, the fraud occurs when a claim is made for Medicare reimbursement for an unnecessary or overpriced procedure. If the Justice Department joins the case and it results in a court ruling or settlement agreement, the whistleblower typically receives a portion of the resulting payout. In this study, researchers looked at PCI-related whistleblower claims, identifying 16 hospitals that were investigated in Florida, Kentucky, Maryland and New Jersey between 2007 and 2015. According to their findings, 15 of the cases were resolved with a settlement agreement, and three cases resulted in defendants going to prison. The researchers note that many of the cases were based on doctors overstating the degree of stenosis suffered by the patient, which they suggest could mean rates of unnecessary heart stent operations are underestimated. However, the study also found that the number of PCI procedures declined at the investigated hospitals after every investigation. “It is difficult to precisely identify the association of the investigations with PCI use. Declines in procedure volumes at each hospital that was investigated generally coincide with the initiation of the investigations,” the researchers concluded. “The investigations may have led physicians at non-investigated hospitals to adopt more conservative practice styles.” One of the highest profile cases was one involving Dr, Mark Midei, a former St. Joseph Medical Center cardiologist who has since been stripped of his medical license. In 2013 a Maryland jury determined that both Midei and the hospital were liable for implanting unnecessary heart stents. The discovery of the problems with unnecessary heart stents by Dr. Midei was first uncovered by a U.S. Justice Department (DOJ) investigation into Medicare fraud and claims of kickbacks between the hospital and the MidAtlantic Cardiovascular Associates (MACVA), of which Midei was a member at one time. He was kicked out of his position at the hospital shortly after the investigation got underway. Settlement agreements were reached in nearly 250 lawsuits against St. Joseph and Midei. As a result of the unnecessary procedures, St. Joseph also reached a $22 million settlement with the DOJ in 2010. Tags: Dr. Mark Midei, Heart Stent, Maryland, Medical Malpractice, Qui Tam, St. Joseph Medical Center, Stent, Whistleblower More Whistleblower Lawsuit Stories NHTSA Whistleblower Settlement Results In $24M Payment For Uncovering Kia, Hyundai Safety Violations November 10, 2021 SEC Whistleblower Settlements Have Resulted in $1 Billion in Awards Paid For Uncovering Violations of Securities Laws September 20, 2021 Whistleblower Lawsuit Over AstraZeneca Off-Label Marketing Ends in $2.4M Verdict June 24, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
NHTSA Whistleblower Settlement Results In $24M Payment For Uncovering Kia, Hyundai Safety Violations November 10, 2021
SEC Whistleblower Settlements Have Resulted in $1 Billion in Awards Paid For Uncovering Violations of Securities Laws September 20, 2021
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: yesterday) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: 2 days ago) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)